RhumbLine Advisers’s Quince Therapeutics QNCX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-394
| Closed | -$295 | – | 4308 |
|
|
2024
Q2 | $295 | Hold |
394
| – | – | ﹤0.01% | 4308 |
|
|
2024
Q1 | $417 | Hold |
394
| – | – | ﹤0.01% | 4196 |
|
|
2023
Q4 | $413 | Hold |
394
| – | – | ﹤0.01% | 4208 |
|
|
2023
Q3 | $441 | Hold |
394
| – | – | ﹤0.01% | 4237 |
|
|
2023
Q2 | $592 | Buy |
+394
| New | +$592 | ﹤0.01% | 4314 |
|
|
2022
Q2 | – | Sell |
-19,411
| Closed | -$120K | – | 3208 |
|
|
2022
Q1 | $120K | Buy |
19,411
+238
| +1% | +$1.47K | ﹤0.01% | 2855 |
|
|
2021
Q4 | $242K | Sell |
19,173
-620
| -3% | -$7.83K | ﹤0.01% | 2776 |
|
|
2021
Q3 | $1.81M | Buy |
19,793
+822
| +4% | +$75.3K | ﹤0.01% | 1964 |
|
|
2021
Q2 | $1.01M | Buy |
18,971
+717
| +4% | +$38K | ﹤0.01% | 2245 |
|
|
2021
Q1 | $658K | Sell |
18,254
-1,097
| -6% | -$39.5K | ﹤0.01% | 2365 |
|
|
2020
Q4 | $538K | Buy |
19,351
+1,112
| +6% | +$30.9K | ﹤0.01% | 2413 |
|
|
2020
Q3 | $912K | Sell |
18,239
-2,400
| -12% | -$120K | ﹤0.01% | 2032 |
|
|
2020
Q2 | $956K | Buy |
20,639
+6,998
| +51% | +$324K | ﹤0.01% | 2067 |
|
|
2020
Q1 | $622K | Buy |
13,641
+2,570
| +23% | +$117K | ﹤0.01% | 2076 |
|
|
2019
Q4 | $622K | Buy |
+11,071
| New | +$622K | ﹤0.01% | 2278 |
|